Is there an association between exposure to environmental estrogens and breast cancer?

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 3, 1997, Pages 675-678

  Safe, Stephen H ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Breast cancer; Estrogens; Hydroxylase activity; Organochlorines

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; BENZO[A]PYRENE; CHLORPHENOTANE; ESTROGEN; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; ORGANOCHLORINE DERIVATIVE; POLYCHLORINATED BIPHENYL;

BREAST CANCER; CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030925236     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s3675     Document Type: Conference Paper

References (49)

1. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83:2496-2500 (1986).
2. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132:2279-2286 (1993).
3. Korach KS, Sarver P, Chae K, McLachlan JA, McKinney JD. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes. Mol Pharmacol 33:120-126 (1988).
4. Soto AM, Chung KL, Sonnenschein C. The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect 102:380-383 (1994).
5. Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonylphenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect 92:167-173 (1991).
6. White R, Jobling S, Hoare SA, Sumpter JP, Parker MG. Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 135:175-182 (1993).
7. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-screen assay as a tool to identify estrogens - an update on estrogenic environmental pollutants. Environ Health Perspect 103:113-122 (1995).
8. Colborn T, Vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101:378-384 (1993).
9. Sharpe RM, Skakkebaek NF. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341:1392-1395 (1993).
10. Sharpe RM. Reproductive biology. Another DDT connection. Nature 375:538-539 (1995).
11. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for the decreasing quality of semen during the past 50 years. Br Med J 305:609-612 (1992).
12. Auger J, Kuntsmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 332:281-285 (1985).
13. Bendvold E, Gottlieb C, Bygdeman M, Eneroth P. Depressed semen quality in Swedish men from barren couples: a study over three decades. Arch Androl 26:189-194 (1991).
14. Irvine S, Cawood E, Richardson D, MacDonald E, Aitken J. Evidence of deteriorating semen quality in the United Kingdom: birth cohort study in 577 men in Scotland over 11 years. Br Med J 312:467-471 (1996).
15. Fisch H, Goluboff ET, Olson JH, Feldshuh J, Broder SJ, Barad DH. Semen analyses in 1,283 men from the United States over a 25-year period: no decline in quality. Fertil Steril 65:1009-1014 (1996).
16. Paulsen CA, Berman NG, Wang G. Data from men in greater Seattle area reveals no downward trend in semen quality: further evidence that deterioration of semen quality is not geographically uniform. Fertil Steril 65:1015-1020 (1996).
17. Bujan L, Mansat A, Pontonnier F, Mieusset R. Time series analysis of sperm concentration in fertile men in Toulouse, France between 1977 and 1992. Br Med J 312:471-472 (1996).
18. Macleod J, Wang Y. Male fertility potential in terms of semen quality: a review of the past, a study of the present. Fertil Steril 31:103-116 (1979).
19. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377 (1993).
20. Davis DL, Bradlow HL. Can environmental estrogens cause breast cancer. Sci Am 273:166-171 (1995).
21. Hulka BS, Liu ET, Lininger RA. Steroid hormones and risk of breast cancer. Cancer 74:1111-1124 (1994).
22. Wolff MS, Toniolo PG, Leel EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85:648-652 (1993).
23. Falck F, Ricci A, Wolff MS, Godbold J, Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47:143-146 (1992).
24. Dewailly E, Dodin S, Verreault R, Ayotte P, Sauvé L, Morin J, Brisson J. High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst 86:232-234 (1994).
25. Mussalo-Rauhamaa H, Häsänen E, Pyysalo H, Antervo K, Kauppila R, Pantzar P. Occurrence of β-hexachlorocyclohexane in breast cancer patients. Cancer 66:2124-2128 (1990).
26. Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst 86:589-599 (1994).
27. Key T, Reeves G. Organochlorines in the environment and breast cancer. Br Med J 308:1520-1521 (1994).
28. Ahlborg UG, Lipworth L, Titusernstoff L, Hsieh CC, Hanberg A, Baron J, Trichopoulos D, Adami HO. Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: as assessment of the biological and epidemiological evidence. Crit Rev Toxicol 25:463-531 (1995).
29. Adami HO, Lipworth L, Titusernstoff L, Hsieh CC, Hanberg A, Ahlborg U, Baron J, Trichopoulos D. Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control 6:551-566 (1995).
30. Wolff MS. Pesticides - how research has succeeded and failed in informing policy: DDT and the link with breast cancer. Environ Health Perspect 103(Suppl 6):87-91 (1995).
31. Ekbom A, Wicklund-Glynn A, Adami HO. DDT and testicular cancer. Nature 347:553-554 (1996).
32. Safe S. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol Therap 67:247-281 (1995).
33. Safe S. Environmental and dietary estrogens and human health - is there a problem? Environ Health Perspect 103:346-351 (1995).
34. Scribner JD, Mottet NK. DDT acceleration of mammary gland tumors induced in the male Sprague-Dawley rat by 2-acetamidophenanthrene. Carcinogenesis 2:1235-1239 (1981).
35. Silinskas KC, Okey AB. Protection by 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) against mammary tumors and leukemia during prolonged feeding of 7,12-dimethyl-benz(a)anthracene to female rats. J Natl Cancer Inst 55:653-657 (1975).
36. Henderson AK, Rosen D, Miller GL, Figgs LW, Zahm SH, Sieber SM, Humphrey HEB, Sinks T. Breast cancer among women exposed to polybrominated biphenyls. Epidemiology 6:544-546 (1995).
37. Bradlow HL, Davis DL, Lin G, Sepkovic D, Tiwan RK. The ratio of 16α/2-hydroxyestrone as a biologic marker of breast cancer risk. Environ Health Perspect 103:147-150 (1995).
38. Schneider J, Kinne D, Fracchia A, Pierce V, Anderson KE, Bradlow HL, Fishman J. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci USA 79:3047-3051 (1982).
39. Bradlow HL, Hershcopf RJ, Martucci CP, Fishman J. Estradiol 16α-hydroxylation in the mouse correlate with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci USA 82:6295-6299 (1985).
40. Osborne MP, Bradlow HL, Wong GY, Telang NT. Upregulation of estradiol C16 α-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J Natl Cancer Inst 85:1917-1920 (1993).
41. Swaneck GE, Fishman J. Covalent binding of the endogenouse estrogen 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc Natl Acad Sci USA 85:7831-7835 (1988).
42. Bradlow HL, Michnovicz JJ, Telang NT, Osborne MP. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12:1571-1574 (1991).
43. Grubbs CJ, Steele VE, Casebolt T, Juliana MM, Eto I, Whitaker LM, Dragnev KH, Kelloff GJ, Lubet RL. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15:709-716 (1995).
44. Tiwari RK, Guo L, Bradlow HL, Telang NT, Osborne MP. Selective responsiveness of breast cancer cells to indole-3-carbinol, a chemopreventative agent. J Natl Cancer Inst 86:126-131 (1994).
45. Chen I, Safe S, Bjeldanes L. Indole-3-carbinol and diindolyl-methane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem Pharmacol 51:1069-1076 (1996).
46. Connor K, Howell J, Chen I, Liu H, Berhane K, Sciarretta C, Safe S, Zacharewski T. Failure of chloro-s-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Fundam Appl Toxicol 30:93-101 (1996).
47. McDougal A, Wilson C, Safe S. Unpublished data.
48. Chaloupka K, Krishnan V, Safe S. Polynuclear aromatic hydrocarbon carcinogens as antiestrogens in MCF-7 human breast cancer cells. Role of the Ah receptor. Carcinogenesis 13:2223-2239 (1992).
49. Aldercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hämäläinen E. Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst 86:1076-1082 (1994).